- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02927730
The Correlation Between Clinical Diagnosis of Retained Placenta And Histology (WHI)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Background:
Retained products of conception (RPOC) are a common and treatable complication after delivery or termination of pregnancy. The reported incidence in the literature is around 1% of all pregnancies. Most often, diagnoses are made on clinical basis and there is only scarce information available related to the correlation between the clinical and pathological diagnosis of RPOC. The gold standard for diagnosis of RPOC is based on histopathological confirmation of chorionic villi in tissue derived from the uterus. Once RPOC is diagnosed on a clinical basis, several treatment options are available, including expectant management, pharmacological treatment, and surgical interventions. Given the risks associated with surgical interventions, accurate diagnosis is vital. Guidelines at Maccabi Health Care Organization mandate that hysteroscopic removal of suspected RPOC should be performed only after approval by a Gynecological Surgical Preauthorization committee. Based on the activity of this committee and starting 2011, Maccabi has developed a database on certain gynecologic-surgical procedures including hysteroscopic removal of suspected RPOC.
Purpose of the study:
The main purpose is to evaluate the correlation in qualitative and quantitative manner between clinical diagnosis of retained placenta and histology.
Expected results:
70% correlation between the clinical and pathological diagnosis of RPOC.
Methods:
Establishing a dedicated database which includes demographic, clinical and histological data of women who have undergone hysteroscopic removal of suspected RPOC and statistical assessment of correlations.
Significance:
Determination of the correlation between clinical suspicion and histological diagnosis of retained placental tissue Finding clinical parameters that may increase the accuracy of this diagnosis and will help to prevent unnecessary procedures.
Study Type
Enrollment (Actual)
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Women who diagnosed clinically with RPOC
- women who prefomed therapeutic hysteroscopy under the diagnosis of RPOC
Exclusion Criteria:
- Women who underwent hysteroscopy presumptive diagnosis of RPOC without documentation of pathological results were excluded.
- Women who have not performed / recorded sonography test before the hysterocpy.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
positive retainted placenta histology
base on chorionic villi in the pathalogic sample
|
no interventions
|
|
negative retainted placenta histology
|
no interventions
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
the correlation between clinical suspicion and histological diagnosis of retained placental tissue Finding is 67.5 %.
Time Frame: sep-oct 2016
|
sep-oct 2016
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
No clinical symptoms increase the accuracy of this diagnosis. There no advantage in the use of diagnostic hysteroscopy in case of suspected retainted placenta.
Time Frame: sep-oct 2016
|
sep-oct 2016
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- BaitBHresiduaCTIL
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Retained Product of Pregnancy
-
Yael YagurMeir Hospital, Kfar Saba, IsraelRecruitingRetained Product of Conception After First Trimester Medical AbortionIsrael
-
Prisma Health-UpstateRecruiting
-
Assuta Ashdod HospitalRecruitingRetained Products of ConceptionIsrael
-
Assaf-Harofeh Medical CenterCompletedRetained Products of ConceptionIsrael
-
The Third Xiangya Hospital of Central South UniversityHunan Provincial People's Hospital; ZhuZhou Central Hospital; The First People... and other collaboratorsRecruitingRetained Products of Conception | RPOCChina
-
Meir Medical CenterUnknownRetained Products of Conception Post Abortion
-
University Hospital, GhentCompletedIntoxication | Unintended Ingestion of ProductBelgium
-
Wafaa Uthman AhmedAin Shams Maternity HospitalUnknownCARBETOCIN FOR PREVENTION OF PLACENTAL RETAINEDEgypt
-
Hawler Medical UniversityCompleted
-
Mahidol UniversityCompletedRetained PlacentaThailand
Clinical Trials on no interventions
-
National Taiwan University HospitalNot yet recruitingThe Cardiac Function
-
Chinese University of Hong KongRecruiting
-
Marmara UniversityCompleted
-
Royal Brompton & Harefield NHS Foundation TrustRecruitingIdiopathic Pulmonary Fibrosis (IPF) | Progressive Pulmonary FibrosisUnited Kingdom
-
University of IoanninaEnrolling by invitationCarpal Tunnel Syndrome (CTS)Greece
-
Sohag UniversityNot yet recruitingCKD on Hemodialysis Patients
-
Marisse Masis-SolanoIriscience IncNot yet recruitingGlaucoma | Macular Degeneration | Cataract | Keratoconus | Diabetic Retinopathy (DR)Costa Rica
-
Peking University People's HospitalRecruitingOsteoporosis | OsteoarthitisChina
-
Sigmund Freud PrivatUniversitatNot yet recruiting
-
Peking Union Medical College HospitalNot yet recruiting